|
Controlled medicines, pharmaceutical starting materials |
|
|
|
|
Medicines without marketing authorization in Viet Nam |
|
|
|
|
Narcotic pharmaceutical substances specified in Annex I in conjunction with Circular No.20/2017/TT-BYT |
|
|
|
|
Pharmaceutical starting materials that are pharmaceutical substances without marketing authorization in Viet Nam |
|
|
|
|
Precursors for medicine production specified in Annex III in conjunction with Circular No.20/2017/TT-BYT |
|
|
|
|
Psychotropic pharmaceutical substances specified in Annex II in conjunction with Circular No.20/2017/TT-BYT |
|
|
|
|
Radioactive substances used in the health sector as provided in Annex IV in conjunction with Decree No. 54/2017/ND-CP |
|
|
|
|
Toxic medicines and toxic pharmaceutical starting materials for medicine production issued in conjunction with Circular No.06/2017/TT-BYT |
|
|
|
